Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-710-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.05 mg/m³
- Most sensitive endpoint:
- developmental toxicity / teratogenicity
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 520 mg/m³
- Most sensitive endpoint:
- acute toxicity
DNEL related information
- Overall assessment factor (AF):
- 7.5
- Modified dose descriptor starting point:
- NOAEC
Local effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.05 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 3.9 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 1
- Dose descriptor starting point:
- NOAEC
Workers - Hazard via dermal route
Systemic effects
Acute/short term exposure
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1.3 mg/cm²
- Most sensitive endpoint:
- sensitisation (skin)
DNEL related information
- Overall assessment factor (AF):
- 1
- Dose descriptor:
- other: NOAEL
Workers - Hazard for the eyes
Additional information - workers
Nickel Oxyhydroxide CSR Table for Workers
Note 1. Exposures are always given in terms of mg nickel and NOT as mg substance.
Note 2. In cases where existing standards (OELs in case of workers, ambient air standards in case of general public) are used instead of DNEL/DMEL, the fields for Assessment factors and Corrected Dose descriptor were left blank. Further information on the air standard derivation is contained in the documents referenced in the Table below.
Note 3. Acute systemic and local effects are relevant for short-term worker’s exposure (peak exposure of 15 minutes to a few hours). Long-term systemic and local effects are relevant to long-term worker’s exposure defined as 8 hours/day and 5 days per week for a working life.
Exposure pattern |
Route |
Descriptor |
DNEL / DMELa |
AF |
Corrected Dose descriptor |
Most sensitive endpoint |
Justification |
Acute - systemic effects |
Dermal |
|
|
|
|
|
Not relevant, negligible absorption |
Acute - systemic effects |
Inhalation |
DNEL (Derived No Effect Level) |
520 mg Ni/m³ (MMAD = 2.5 -3.75 µm)b |
7.5c |
NOAEC: 3,900 mg Ni/m3 (MMAD = 2.5 -3.75 µm) |
acute toxicity (mortality) |
See footnotes |
Acute - local effects |
Dermal |
|
|
|
|
|
Not relevant, slightly irritating. See footnote (f) |
Acute - local effects |
Inhalation |
DNEL (Derived No Effect Level) |
3.9 mg Ni/m³ ((MMAD =2.9 µm)b |
1d |
NOAEC: 3.9 mg Ni/m3 (MMAD =2.9 µm) |
repeated dose toxicity (lung inflammation) |
See footnotes |
Long-term - systemic effects |
Dermal |
|
|
|
|
|
Not relevant, negligible absorption |
Long-term - systemic effects |
Inhalation |
DNEL (Derived No Effect Level) |
0.05 mg Ni/m³ Inhalable fractione |
|
|
developmental toxicity |
See footnotes |
Long-term - local effects |
Dermal |
DNEL (Derived No Effect Level) |
1.3 mg Ni/cm² |
1f |
NOAEL correctedg: 1.3 mg Ni/cm² from0.00044mg Ni/cm² (sulphate) |
sensitisation (skin) |
See footnotes |
Long-term - local effects |
Inhalation |
DNEL (Derived No Effect Level) |
0.05 mg Ni/m³ Inhalable fractione |
|
|
carcinogenicity and repeated toxicity (respiratory tract- inhalation) |
See footnotes |
a. The approaches used in the derivation of DNELs are described in a report prepared by VITO Consultancy () and included in Appendix C1-C2.
b. The DNEL based on acute toxicity-local effects (lung inflammation) read across from Ni oxide corresponds to an aerosol of MMAD = 2.9 µm. This value should be compared to workplace exposures comprised of particles of MMAD = 2.9 µm. The proper comparisons should take into account the equivalent deposited doses per unit surface area in the respiratory tract of rats exposed to experimental aerosols and of humans exposed to workplace aerosols. If this DNEL value is used in a direct comparison to workplace exposures with MMAD ≥ 30 µm, this value is likely to overestimate risk by ≥ 4-fold. For more details see Appendix C3.
c. Assessment Factor (AF) = 7.5. [AF interspecies differences in susceptibility (AS) = 1 for exposures expressed as concentrations mg/m3, and for lethal effects; AF interspecies differences in susceptibility= 2.5; AF intraspecies differences in susceptibility =5; Overall AF = 2.5 x 5=12.5]
d. AF = 1.0. [AF interspecies difference (AS) = 1 local respiratory effects. AF interspecies difference in susceptibility = 1 (for respiratory toxicity effects after inhalation of particles of nickel or most metal-containing substances in the respirable range, 1-5 µm diameter, rats seem to be more susceptible to toxicity effects than mice, primates or humans. See Appendix C1-C2); AF intraspecies differences in susceptibility=3. AF for conversion of LOAEC to NOAEC=1; AF for exposure duration= 1/9 (used in 2008/2009 EU NICKEL SULPHATE RISK ASSESSMENT), since the duration is longer than in an acute study (12 exposures of 6 hours each during 16 days versus a single 4-hour exposure in an acute guidance study). Overall AF= 1 x 3 x 1 x 1/9 = 0.3. Use AF of 1]
e. The justification for the use of an inhalable OEL of 0.05 mg Ni/m3is provided in Appendix C3. This value is based on the SCOEL proposed OEL for nickel of 0.01 mg Ni/m3(March 2009) with further adjustments for differences in particle size distributions between animal experiments and workplace exposures and differences in sampling efficiency between 37-mmm and inhalable samplers. The SCOEL value and the IND-revised value are based on toxicity local effects observed on the lungs of rats after inhalation and carcinogenicity effects in the respiratory tract observed in human studies. Both values consider nickel compounds to be genotoxic carcinogens with a practical threshold. These values are also protective against possible reproductive effects.
f. AF =1. Study done in humans, 48 hours under occlusion. The population at risk of having an exacerbation of dermal symptoms after oral challenge consists of patients with severe nickel sensitisation. The derivation of a DNEL for dermal sensitization by nickel hydroxide is a conservative approach since no classification appears to be warranted for this endpoint based on Ni release in sweat.This DNEL is protective of both acute and long-term local dermal effects.
g. Corrected dose descriptor = 1.3 mg Ni/cm2[0.44 µg Ni/cm2x 3,000 = 1.3 mg Ni/cm2); 3,000-fold less release of Ni from nickel hydroxide than from Ni sulphate after 24 hours, 37C in sweat, KMHC, 2010. The DNEL for dermal sensitization/elicitation is based on a patch test study where exposure lasted for 48hs under occlusion.
Appendix C1 = Derivation of DNELs for 4 Reference Ni substances
Appendix C2 = Detailed tables of DNEL derivations –nickel dihydroxide
Appendix C3 = Background document in support of use of Indicative OEL for nickel substances
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 20 ng/m³
- Most sensitive endpoint:
- sensitisation (skin)
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 312 mg/m³
- Most sensitive endpoint:
- acute toxicity
DNEL related information
- Overall assessment factor (AF):
- 12.5
- Modified dose descriptor starting point:
- NOAEC
Local effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 20 ng/m³
- Most sensitive endpoint:
- repeated dose toxicity
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 3.9 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 1
- Dose descriptor starting point:
- NOAEC
General Population - Hazard via dermal route
Systemic effects
Acute/short term exposure
DNEL related information
General Population - Hazard via oral route
Systemic effects
Acute/short term exposure
DNEL related information
General Population - Hazard for the eyes
Additional information - General Population
Note 1. Exposures are always given in terms of mg nickel and NOT as mg substance.
Note 2. In cases where existing standards (OELs in case of workers, ambient air standards in case of general public) are used instead of DNEL/DMEL, the fields for Assessment factors and Dose descriptor Starting Points were left blank. Further information on the Standard derivation is contained in the documents referenced in the Table below.
Note 3. Acute systemic and local effects are relevant for short-term exposure (peak exposure of 15 minutes to a few hours). Long-term systemic and local effects are relevant to long-term exposure defined as 24 hours/day and 7 days per week for a life-time.
Exposure pattern |
Route |
Descriptor |
DNEL / DMELa |
AF |
Corrected Dose descriptor |
Most sensitive endpoint |
Justification |
Acute - systemic effects |
Dermal |
|
|
|
|
|
Not relevant, negligible exposure and absorption |
|
Inhalation |
DNEL (Derived No Effect Level) |
312 mg Ni/m³b
|
12.5c |
NOAEC: 3,900 mg Ni/m3
|
acute toxicity (mortality) |
See footnotes |
|
Oral |
|
|
|
|
|
Not relevant, negligible oral exposure |
Acute - local effects |
Dermal |
|
|
|
|
|
Not relevant, not irritant |
|
Inhalation |
DNEL (Derived No Effect Level) |
3.9 mg Ni/m³b
|
1d |
NOAEC: 3.9 mg Ni/m3
|
repeated dose toxicity (lung inflammation) |
See footnotes |
Long-term - systemic effects |
Dermal |
|
|
|
|
|
Not relevant, negligible exposure and absorption |
|
Inhalation |
DNEL (Derived No Effect Level) |
0.00002mg Ni/m3e |
|
|
exacerbation of existing dermatitis |
See footnotes |
|
Oral |
|
|
|
|
|
Not relevant, negligible oral exposure |
Long-term - local effects |
Dermal |
|
|
|
|
|
Not relevant, negligible exposure |
|
Inhalation |
DNEL (Derived No Effect Level) |
0.00002mg Ni/m3e |
|
CSTEE (ambient air standard) = 0.00002mg Ni/m3 |
repeated dose toxicity (lung inflammation) Carcinogenicity |
See footnotes |
a. The approaches used in the derivation of DNELs are described in a report prepared by VITO Consultancy and included in Appendix C1-C2.
b. The DNEL value for acute effects after inhalation is superseded by the CSTEE, EU Scientific Committee on Toxicity, Ecotoxicity and the Environment (2001) proposed ambient air guidance value of 0.00002 mg Ni/m3as discussed in Appendices C1-C2 and D5.
c. Assessment Factor (AF) = 12.5. [AF interspecies differences in susceptibility (AS) = 1 for exposures expressed as concentrations mg/m3, and for lethal effects; AF interspecies differences in susceptibility= 2.5; AF intraspecies differences in susceptibility =10; Overall AF = 2.5 x 5=12.5]
d. AF = 1. [AF interspecies difference (AS) = 1 local respiratory effects. AF interspecies difference in susceptibility = 1 (for respiratory toxicity effects after inhalation of particles of nickel or most metal-containing substances in the respirable range, 1-5 µm diameter, rats seem to be more susceptible to toxicity effects than mice, primates or humans. See Appendices C1 and C2); AF intraspecies differences in susceptibility=5. AF for conversion of LOAEC to NOAEC=1 (Ni oxide); AF for exposure duration= 1/9 (used in 2008/2009 EU NICKEL METAL RISK ASSESSMENT), since the duration is longer than in an acute study (12 exposures of 6 hours each during 16 days versus a single 4-hour exposure in an acute guidance study). Overall AF= 1 x 5 x 1 x 1/9 = 0.6. Use AF of 1].
e. We used the CSTEE, EU Scientific Committee on Toxicity, Ecotoxicity and the Environment (2001) ambient air recommended nickel value of 20 ng Ni/m3instead of a DMEL based on carcinogenicity or a DNEL based on long term-local respiratory effects. The CSTEE value is based on considerations of both respiratory toxicity and carcinogenicity and it is also protective from systemic exacerbation of dermatitis in sensitized individuals (see Appendix C1 -C2 and Appendix D5).
Appendix C1 = Derivation of DNELs for 4 Reference Ni substances
Appendix C2 = Detailed table of DNEL derivations –nickel dihydroxide
Appendix D5 = Man Via the Environment Risk Assessment
Sensitive subpopulations. Sensitive subpopulations are not separately addressed as the oral DNEL values used correspond to the TDI calculated by WHO for the general public and the inhalation DNEL-DMEL value used corresponds to the ambient air guidance value derived by CSTEE for the EU general public.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.